18244 Federal Register / Vol. 74, No. 75 / Tuesday, April 21, 2009 / Notices 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel. 

Review for Registry and Surveillance System 

in Hemoglobinopathies (RuSH) Pilot Studies. 

Date: May 11, 2009. 

Time: 9:30 a.m. to 2 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924. 301–435–0725. 

johnsonwj@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: April 15, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–9133 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting; Moving Into the 

Future—New Dimensions and 

Strategies for Women’s Health 

Research for the National Institutes of 

Health 

Notice is hereby given that the Office 

of Research on Women’s Health 

(ORWH), Office of the Director, National 

Institutes of Health, Department of 

Health and Human Services, in 

collaboration with the Department of 

Obstetrics, Gynecology and 

Reproductive Sciences at the University 

of California, San Francisco (UCSF), 

will convene a public hearing and 

scientific workshop on May 27–29, 

2009, at the UCSF, Mission Bay 

Conference Center, San Francisco, 

California. 

Purpose of the Meeting 

With rapid advances in science and 

wider global understanding of women’s 

health and sex/gender contributions to 

well-being and disease, the purpose of 

the meeting is to ensure that NIH 

continues to support cutting edge 

women’s health research that is based 

upon the most advanced techniques and 

methodologies. The meeting format is 

designed to promote an interactive 

discussion involving leading scientists, 

advocacy groups, public policy experts, 

health care providers, and the general 

public. The San Francisco meeting is 

the second in a series that will be 

convened throughout the Nation to 

assist the ORWH and the NIH to move 

into the next decade of women’s health 

research. 

As science and technology advance 

and fields such as computational 

biology demonstrate the power of 

interdisciplinary research, it remains 

critical for sex and gender factors to be 

integrated into broad experimental 

methodologies and scientific 

approaches such as stem cell research. 

Biomedical and behavioral research are 

also necessary to understand how 

cultural, ethnic, and racial differences 

influence the causes, diagnosis, 

progression, treatment, and outcome of 

disease among different populations, 

including women of diverse geographic 

locations and socioeconomic 

backgrounds. Furthermore, health 

differences among diverse populations 

of women remain a critical area in need 

of continued focus and attention. 

The ORWH challenges all meeting 

attendees to assist the NIH in defining 

the women’s health research agenda of 

the future, thinking beyond traditional 

women’s health issues. The attendees 

need to identify creative strategies and 

areas of research that are best poised for 

advancement, address innovative ways 

to approach persistent issues of health 

and disease, and explore new scientific 

concepts and investigative approaches. 

The attendees need to pay attention to 

new areas of science application, new 

technologies, and continuing basic 

science investigations. The attendees 

should also consider clinical questions 

that are not currently the focus of 

research priorities to ensure that 

women’s health research is optimally 

served and that the ORWH can continue 

to provide leadership for the benefit of 

women’s health, nationally and 

internationally. 

Meeting Format 

The meeting will consist of public 

testimony, scientific panels, and six 

concurrent scientific working groups. 

Specifically, on May 27, individuals 

representing a full spectrum of 

organizations interested in biomedical 

and behavioral research on women’s 

health issues will have an opportunity 

to provide public testimony from 2–6 

p.m. On May 28 and 29, plenary 

sessions will focus on the intersection of 

health care, public policy, and 

biomedical research; on emerging issues 

and trends in health care; and on 

research paradigms of the future. The 

six concurrent afternoon sessions on 

May 28 will focus on a range of research 

areas, including global health, stem cell 

research, environmental health and 

reproduction, HIV/AIDS and women, 

information technology, and women in 

biomedical careers. On May 29, the 

morning session will be devoted to 

reports by the working group co-chairs 

regarding the recommendations 

emerging from working group 

deliberations on the previous day. The 

meeting will adjourn at 1 p.m. on May 

29. 

Public Testimony 

ORWH invites individuals with an 

interest in research related to women’s 

health to provide written and/or oral 

testimony on these topics and/or on 

issues related to the sustained 

advancement of women in biomedical 

careers. Due to time constraints, only 

one representative from an organization 

or professional specialty group may 

submit oral testimony. Individuals not 

representing an organized entity but a 

personal point of view are similarly 

invited to present written and/or oral 

testimony. A letter of intent to present 

oral testimony is necessary and should 

be sent electronically to http:// 

www.orwhmeetings.com/ 

movingintothefuture/ or by mail to Ms. 

Jory Barone, Educational Services, Inc., 

4350 East-West Highway, Suite 1100, 

Bethesda, MD 20814, no later than May 

15, 2009. The date of receipt of the 

communication will establish the order 

of those selected to give oral testimony 

at the May meeting. 

Those wishing to present oral 

testimony are also asked to submit a 

written form of their testimony that is 

limited to a maximum of 10 pages, 

double spaced, 12 point font, and 

should include a brief description of the 

organization. Electronic submission to 

the above Web site is preferred; 

however, for those who do not have 

access to electronic means, written 

testimony, bound by the restrictions 

previously noted and postmarked no 

later than May 15, 2009, may be mailed 

to Ms. Jory Barone at the above address. 

All written presentations must meet the 

established page limitations. 

Submissions exceeding this limit will 

not be accepted and will be returned. 

Oral testimony of this material at the 

meeting will be limited to no more than 

5–7 minutes in length. 

Because of time constraints for oral 

testimony, testifiers may not be able to 

present the complete information as it is 

contained in their written form 

submitted for inclusion in the public 

record of the meeting. Therefore, 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 75 / Tuesday, April 21, 2009 / Notices 18245 

testifiers are requested to summarize the 

major points of emphasis from the 

written testimony, not to exceed 7 

minutes of oral testimony. Those 

individuals and/or organizations who 

have indicated that they will present 

oral testimony at the meeting in San 

Francisco will be notified prior to the 

meeting regarding the approximate time 

for their oral presentation. 

Individuals and organizations wishing 

to provide written statements only 

should send a copy of their statements, 

electronically or by mail, to the above 

Web site or address by May 15, 2009. 

Written testimony received by that date 

will be made available at the May 27– 

29 meeting. Logistics questions related 

to the May meeting should be addressed 

to Ms. Jory Barone at ESI, while 

program-specific questions should be 

addressed to Ms. Jennifer Millis at the 

University of California, San Francisco, 

415–502–2563, millisj@obgyn.ucsf.edu. 

This meeting is the second of four 

regional public hearings and scientific 

workshops of similar design to be 

convened by the ORWH. At the 

conclusion of the regional meetings, the 

ORWH will hold a meeting at the NIH 

to develop a summation of the 

deliberations from the regional 

meetings. The resulting report to the 

ORWH and the NIH will ensure that 

women’s health research in the coming 

decade continues to support a vigorous 

research agenda incorporating the latest 

advances in technology and cutting edge 

science. 

Dated: April 14, 2009. 

Raynard S. Kington, 

Acting Director, National Institutes of Health. 

[FR Doc. E9–9131 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–1829– 

DR; Docket ID FEMA–2008–0018] 

North Dakota; Amendment No. 1 to 

Notice of a Major Disaster Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of a major disaster declaration for the 

State of North Dakota (FEMA–1829– 

DR), dated March 24, 2009, and related 

determinations. 

DATES: Effective Date: April 6, 2009. 

FOR FURTHER INFORMATION CONTACT: 

Peggy Miller, Disaster Assistance 

Directorate, Federal Emergency 

Management Agency, 500 C Street, SW., 

Washington, DC 20472, (202) 646–3886. 

SUPPLEMENTARY INFORMATION: The 

Federal Emergency Management Agency 

(FEMA) hereby gives notice that 

pursuant to the authority vested in the 

Administrator, under Executive Order 

12148, as amended, Justo Hernandez, of 

FEMA is appointed to act as the Federal 

Coordinating Officer for this declared 

disaster. 

This action terminates my 

appointment of Michael J. Hall as 

Federal Coordinating Officer for this 

disaster. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050, Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

Nancy Ward, 

Acting Administrator, Federal Emergency 

Management Agency. 

[FR Doc. E9–9064 Filed 4–20–09; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–1828– 

DR; Docket ID FEMA–2008–0018] 

Indiana; Amendment No. 1 to Notice of 

a Major Disaster Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of a major disaster declaration for the 

State of Indiana (FEMA–1828–DR), 

dated March 5, 2009, and related 

determinations. 

DATES: Effective Date: April 6, 2009. 

FOR FURTHER INFORMATION CONTACT: 

Peggy Miller, Disaster Assistance 

Directorate, Federal Emergency 

Management Agency, 500 C Street, SW., 

Washington, DC 20472, (202) 646–3886. 

SUPPLEMENTARY INFORMATION: The notice 

of a major disaster declaration for the 

State of Indiana is hereby amended to 

include the following areas among those 

areas determined to have been adversely 

affected by the event declared a major 

disaster by the President in his 

declaration of March 5, 2009. 

Jennnings, Lawrence, Ohio, Posey, Ripley, 

and Scott Counties for Public Assistance. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050 Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

Nancy Ward, 

Acting Administrator, Federal Emergency 

Management Agency. 

[FR Doc. E9–9067 Filed 4–20–09; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–1830– 

DR; Docket ID FEMA–2008–0018] 

Minnesota; Amendment No. 1 to Notice 

of a Major Disaster Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of a major disaster declaration for the 

State of Minnesota (FEMA–1830–DR), 

dated April 9, 2009, and related 

determinations. 

DATES: Effective Date: April 10, 2009. 

FOR FURTHER INFORMATION CONTACT: 

Peggy Miller, Disaster Assistance 

Directorate, Federal Emergency 

Management Agency, 500 C Street, SW., 

Washington, DC 20472, (202) 646–3886. 

SUPPLEMENTARY INFORMATION: The notice 

of a major disaster declaration for the 

State of Minnesota is hereby amended to 

include Individual Assistance for the 

following areas among those areas 

determined to have been adversely 

affected by the event declared a major 

mstockstill on PROD1PC66 with NOTICES